일자 | 시간 | 출처 | 헤드라인 | 심볼 | 기업 |
2018/12/26 | 22:01 | Edgar (US Regulatory) | Termination of Registration of a Class of Security Under Section 12(g) (15-12g) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:02 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/26 | 20:01 | Edgar (US Regulatory) | Notice of Effectiveness (effect) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:42 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:41 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:38 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:37 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:35 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:33 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 06:04 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/14 | 05:54 | Edgar (US Regulatory) | Amended Statement of Beneficial Ownership (sc 13d/a) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 23:20 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 23:17 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 23:13 | Edgar (US Regulatory) | Post-effective Amendment to Proposed Securities Act Rule 462(b) Registration Statement (pos462b) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 23:09 | Edgar (US Regulatory) | Post-effective Amendment to an Automatic Shelf Registration of Form S-3asr or Form F-3asr (posasr) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 22:25 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 22:24 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |
2018/12/13 | 22:20 | Edgar (US Regulatory) | Post-effective Amendment to Registration Statement (pos Am) | NASDAQ:KERX | Keryx Biopharmaceuticals, Inc. (delisted) |